Serum amyloid A in patients with idiopathic pulmonary fibrosis
ConclusionsSAA is a promising marker of disease severity in patients with IPF. Our preliminary data suggest a potential pathogenetic role of alteration in lipid metabolism in this rare disease.
Source: Respiratory Investigation - Category: Respiratory Medicine Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Cholesterol | Chronic Obstructive Pulmonary | Databases & Libraries | Liver | Lung Cancer | Rare Diseases | Respiratory Medicine | Sarcoidosis | Statistics | Study | Urology & Nephrology